According to Lexicon Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 244,925,000. At the end of 2023 the company had 244,925,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.24 B | 29.78% |
2022 | 0.18 B | 26.75% |
2021 | 0.14 B | 21.69% |
2020 | 0.12 B | 15.14% |
2019 | 0.10 B | 0.33% |
2018 | 0.10 B | 0.31% |
2017 | 0.10 B | 1.48% |
2016 | 0.10 B | 0.41% |
2015 | 0.10 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 387,000,000 | 58.01% | ๐บ๐ธ USA |
Illumina ILMN | 158,000,000 | -35.49% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 106,300,000 | -56.60% | ๐บ๐ธ USA |
Ultragenyx RARE | 71,664,493 | -70.74% | ๐บ๐ธ USA |
Ligand Pharmaceuticals LGND | 17,380,000 | -92.90% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | 111,869,478 | -54.33% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | 47,819,936 | -80.48% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | 188,219,000 | -23.15% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | 5,410,000 | -97.79% | ๐บ๐ธ USA |